Lack of endothelium-derived hyperpolarizing factor (EDHF) up-regulation in endothelial dysfunction in aorta in diabetic rats

Pharmacological Reports

Volumn 59, Issue 4, 2007, Pages 447-455

  Csanyi, Gabor ^a   Lepran, Istvan ^b   Flesch, Timea ^a   Telegdy, Gyula ^a   Szabo, Gyula ^a   Mezei, Zsofia ^a  

^a UNIVERSITY OF SZEGED   (Hungary)

^b UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Aorta; Diabetes; EDHF; Eicosanoids; Nitric oxide; Prostaglandins

Indexed keywords

12 LEVO HYDROXY 5,8,10 HEPTADECATRIENOIC ACID; 6 OXOPROSTAGLANDIN F1 ALPHA; ACETYLCHOLINE; ENDOTHELIUM DERIVED HYPERPOLARIZING FACTOR; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITROPRUSSIDE SODIUM; PROSTACYCLIN; PROSTANOID; THROMBOXANE B2; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA DISEASE; ARTERY ENDOTHELIUM; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC ANGIOPATHY; ENDOTHELIAL DYSFUNCTION; MALE; NONHUMAN; PATHOPHYSIOLOGY; PROSTAGLANDIN SYNTHESIS; RAT; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT; STREPTOZOCIN DIABETES; THORACIC AORTA; UPREGULATION; VASOCONSTRICTION; VASODILATATION;

EID: 35048876130     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Bagi Zs, Erdei N, Papp Z, Édes I, Koller A: Up-regulation of vascular cyclooxygenase-2 in diabetes mellitus. Pharmacol Rep, 2006, 58, Suppl, 52-56.
2. Bhardwaj R, Moore PK: Increased vasodilator response to acetylcholine of renal blood vessels from diabetic rats. J Pharm Pharmacol, 1988, 40, 739-742.
3. Bitar MS, Wahid S, Mustafa S, Al-Saleh E, Dhaunsi GS, Al-Mulla F: Nitric oxide dynamics and endothelial dysfunction in type II model of genetic diabetes. Eur J Pharmacol, 2005, 511, 53-64.
4. Campbell WB: New role for epoxyeicosatrienoic acids as anti-inflammatory mediators. Trends Pharmacol Sci, 2000, 21, 125-127.
5. Chudek J, Wiecek A: Adipose tissue, inflammation and endothelial dysfunction. Pharmacol Rep, 2006, 58, Suppl, 81-86.
6. Cosentino F, Eto M, De Paolis P, van der Loo B, Bachschmid M, Ullrich V, Kouroedov A et al.: High glucose causes upregulation of cyclooxygenase-2 and alters prostanoid profile in human endothelial cells: role of protein kinase C and reactive oxygen species. Circulation, 2003, 107, 1017-1023.
7. 2 and EDHF pathways in the aortic endothelium after myocardial infarction in rats. Eur J Heart Fail, 2006, 8, 769-776.
8. Dai FX, Diederich A, Skopec J, Diederich D: Diabetes-induced endothelial dysfunction in streptozotocin-treated rats: role of prostaglandin endoperoxides and free radicals. J Am Soc Nephrol, 1993, 4, 1327-1336.
9. De Vriese AS, Verbeuren TJ, Van de Voorde J, Lameire NH, Vanhoutte PM: Endothelial dysfunction in diabetes. Br J Pharmacol, 2000, 130, 963-974.
10. Diederich D, Skopec J, Diederich A, Dai FX: Endothelial dysfunction in mesenteric resistance arteries of diabetic rats: role of free radicals. Am J Physiol, 1994, 266, 1153-1161.
11. Endo K, Abiru T, Machida H, Kasuya Y, Kamata K: Endothelium-derived hyperpolarizing factor does not contribute to the decrease in endothelium-dependent relaxation in the aorta of streptozotocin-induced diabetic rats. Gen Pharmacol, 1995, 26, 149-153.
12. Fujii K, Soma M, Huang YS, Manku MS, Horrobin DF: Increased release of prostaglandins from the mesenteric vascular bed of diabetic animals: the effects of glucose and insulin. Prostaglandins Leukot Med, 1986, 24, 151-161.
13. Heygate KM, Lawrence IG, Bennett MA, Thurston H: Impaired endothelium-dependent relaxation in isolated resistance arteries of spontaneously diabetic rats. Br J Pharmacol, 1995, 116, 3251-3259.
14. Hishinuma T, Tsukamoto H, Suzuki K, Mizugaki M: Relationship between thromboxane/prostacyclin ratio and diabetic vascular complications. Prostaglandins Leukot Essent Fatty Acids, 2001, 65, 191-196.
15. Hoshiyama M, Li B, Yao J, Harada T, Morioka T, Oite T: Effect of high glucose on nitric oxide production and endothelial nitric oxide synthase protein expression in human glomerular endothelial cells. Nephron Exp Nephrol, 2003, 95, 62-68.
16. Jorgensen RG, Russo L, Mattioli L, Moore WV: Early detection of vascular dysfunction in type I diabetes. Diabetes, 1988, 37, 292-296.
17. Kagota S, Yamaguchi Y, Nakamura K, Kunitomo M: Altered endothelium-dependent responsiveness in the aortas and renal arteries of Otsuka Long-Evans Tokushima Fatty (OLETF) rats, a model of non-insulindependent diabetes mellitus. Gen Pharmacol, 2000, 34, 201-209.
18. Kiefer HC, Johnson CR, Arora KL, Kantor HS: Colorimetric identification of prostaglandins in subnanomole amounts. Anal Biochem, 1975, 68, 336-340.
19. Koltai MZ, Hadhazy P, Posa I, Kocsis E, Winkler G, Rosen P, Pogatsa G: Characteristics of coronary endothelial dysfunction in experimental diabetes. Cardiovasc Res, 1997, 34, 157-163.
20. Majithiya JB, Balaraman R: Metformin reduces blood pressure and restores endothelial function in aorta of streptozotocin-induced diabetic rats. Life Sci, 2006, 78, 2615-2624.
21. Makino A, Ohuchi K, Kamata K: Mechanisms underlying the attenuation of endothelium-dependent vasodilatation in the mesenteric arterial bed of the streptozotocin-induced diabetic rat. Br J Pharmacol, 2000, 130, 549-556.
22. McVeigh GE, Brennan GM, Johnston GD, McDermott BJ, McGrath LT, Henry WR, Andrews JW et al.: Impaired endothelium-dependent and independent vasodilation in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia, 1992, 35, 771-776.
23. Mezei Z, Kis B, Gecse A, Tajti J, Boda B, Telegdy G, Vecsei L: Platelet arachidonate cascade of migraineurs in the interictal phase. Platelets, 2000, 11, 222-225.
24. Mulhern M, Docherty JR: Effects of experimental diabetes on the responsiveness of rat aorta. Br J Pharmacol, 1989, 97, 1007-1012.
25. Palmer AM, Thomas CR, Gopaul N, Dhir S, Anggard EE, Poston L, Tribe RM: Dietary antioxidant supplementation reduces lipid peroxidation but impairs vascular function in small mesenteric arteries of the streptozotocin-diabetic rat. Diabetologia, 1998, 41, 148-156.
26. Pelligrino DA, Koenig HM, Wang Q, Albrecht RF: Protein kinase C suppresses receptor-mediated pial arteriolar relaxation in the diabetic rat. Neuroreport, 1994, 5, 417-420.
27. Peredo HA, Rodriguez R, Susemihl MC, Villarreal I, Filinger E: Long-term streptozotocin-induced diabetes alters prostanoid production in rat aorta and mesenteric bed. Auton Autacoid Pharmacol, 2006, 26, 355-360.
28. Pieper GM, Peltier BA: Amelioration by L-arginine of a dysfunctional arginine/nitric oxide pathway in diabetic endothelium. J Cardiovasc Pharmacol, 1995, 25, 397-403.
29. Pieper GM, Moore-Hilton G, Roza AM: Evaluation of the mechanism of endothelial dysfunction in the genetically-diabetic BB rat. Life Sci, 1996, 58, 147-152.
30. Pieper GM, Siebeneich W: Oral administration of the antioxidant, N-acetylcysteine, abrogates diabetes-induced endothelial dysfunction. J Cardiovasc Pharmacol, 1998, 32, 101-105.
31. Quilley J, McGiff JC: Arachidonic acid metabolism and urinary excretion of prostaglandins and thromboxane in rats with experimental diabetes mellitus. J Pharmacol Exp Ther, 1985, 234, 211-216.
32. Ralevic V, Belai A, Burnstock G: Effects of streptozotocin-diabetes on sympathetic nerve, endothelial and smooth muscle function in the rat mesenteric arterial bed. Eur J Pharmacol, 1995, 286, 193-199.
33. 2 receptor antagonist with minimal intrinsic activity. Br J Haematol, 1998, 101, 59-65.
34. Sadowitz PD, Setty BN, Stuart M: The platelet cyclooxygenase metabolite 12-L-hydroxy-5,8,10-hepta-decatrienoic acid (HHT) may modulate primary hemostasis by stimulating prostacyclin production. Prostaglandins, 1987, 34, 749-763.
35. Schalkwijk CG, Poland DC, van Dijk W, Kok A, Emeis JJ, Drager AM, Doni A et al.: Plasma concentration of C-reactive protein is increased in type I diabetic patients without clinical macroangiopathy and correlates with markers of endothelial dysfunction: evidence for chronic inflammation. Diabetologia, 1999, 42, 351-357.
36. Shimokawa H, Yasutake H, Fujii K, Owada MK, Nakaike R, Fukumoto Y, Takayanagi T et al.: The importance of the hyperpolarizing mechanism increases as the vessel size decreases in endothelium-dependent relaxations in rat mesenteric circulation. J Cardiovasc Pharmacol, 1996, 28, 703-711.
37. Tan KC, Chow WS, Tam SC, Ai VH, Lam CH, Lam KS: Atorvastatin lowers C-reactive protein and improves endothelium-dependent vasodilation in type 2 diabetes mellitus. J Clin Endocrinol Metab, 2002, 87, 563-568.
38. Taylor PD, Graves JE, Poston L: Selective impairment of acetylcholine-mediated endothelium-dependent relaxation in isolated resistance arteries of the streptozotocin-induced diabetic rat. Clin Sci, 1995, 88, 519-524.
39. Wakabayashi I, Hatake K, Kimura N, Kakishita E, Nagai K: Modulation of vascular tonus by the endothelium in experimental diabetes. Life Sci, 1987, 40, 643-648.
40. Wallenstein S, Zucker CL, Fleiss JL: Some statistical methods useful in circulation research. Cire Res, 1980, 47, 1-9.
41. White RE, Carrier GO: Supersensitivity and endothelium dependency of histamine-induced relaxation in mesenteric arteries isolated from diabetic rats. Pharmacology, 1986, 33, 34-38.
42. Wigg SJ, Tare M, Tonta MA, O'Brien RC, Meredith IT, Parkington HC: Comparison of effects of diabetes mellitus on an EDHF-dependent and an EDHF-independent artery. Am J Physiol Heart Circ Physiol, 2001, 281, H232-H240.
43. Ylikorkala O, Kaila J, Viinikka L: Prostacyclin and thromboxane in diabetes. Br Med J, 1981, 283, 1148-1150.